Parkway Wealth Management Group LLC Purchases New Position in SPDR S&P Pharmaceuticals ETF $XPH

Parkway Wealth Management Group LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 380,824 shares of the company’s stock, valued at approximately $24,754,000. SPDR S&P Pharmaceuticals ETF comprises about 2.8% of Parkway Wealth Management Group LLC’s investment portfolio, making the stock its 12th biggest position. Parkway Wealth Management Group LLC owned 0.05% of SPDR S&P Pharmaceuticals ETF as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the stock. Turtle Creek Wealth Advisors LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the 1st quarter worth approximately $26,000. Western Wealth Management LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF in the first quarter valued at approximately $34,000. Fifth Third Bancorp acquired a new stake in SPDR S&P Pharmaceuticals ETF in the first quarter valued at approximately $39,000. TD Waterhouse Canada Inc. acquired a new stake in SPDR S&P Pharmaceuticals ETF in the second quarter valued at approximately $200,000. Finally, Corient Private Wealth LP bought a new stake in shares of SPDR S&P Pharmaceuticals ETF during the second quarter worth $225,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

NYSEARCA XPH opened at $62.24 on Tuesday. The firm’s fifty day moving average price is $67.89 and its two-hundred day moving average price is $63.86. The stock has a market cap of $445.02 million, a PE ratio of 14.28 and a beta of 0.61. SPDR S&P Pharmaceuticals ETF has a fifty-two week low of $47.60 and a fifty-two week high of $74.35.

SPDR S&P Pharmaceuticals ETF Company Profile

(Free Report)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Want to see what other hedge funds are holding XPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Free Report).

Institutional Ownership by Quarter for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.